Treatment choices for diabetic macular oedema: a guideline for when to consider an intravitreal corticosteroid, including adaptations for the COVID-19 era [PDF]
BMJ Open Ophthalmology, 2021 First-line treatment of centrally involved diabetic macular oedema (CI-DMO) is often with an anti-vascular endothelial growth factor (anti-VEGF) agent.
Louise Downey +2 more
exaly +4 more sources
Effect of Alternate Treatment with Intravitreal Corticosteroid and Anti-VEGF for Macular Edema Secondary to Retinal Vein Occlusion [PDF]
Journal of Ophthalmology, 2021 Purpose. To evaluate whether treatment with intravitreal corticosteroid and anti-vascular endothelial growth factor (VEGF) injections alternately can improve treatment outcomes of macular edema (ME) caused by retinal vein occlusion (RVO). Methods.
Young Hwan Bae +5 more
doaj +2 more sources
Analysis of Funding Source and Spin in the Reporting of Studies of Intravitreal Corticosteroid Therapy for Diabetic Macular Edema: A Systematic Review [PDF]
Clinical Ophthalmology, 2020 Harrish Nithianandan,1 Ajay E Kuriyan,2 Michael J Venincasa,3 Jayanth Sridhar3 1Department of Ophthalmology & Visual Sciences, McGill University, Montreal, Quebec, Canada; 2Retina Service, Wills Eye Hospital, Philadelphia, PA, USA; 3Department of ...
Nithianandan H +3 more
doaj +2 more sources
Intravitreal corticosteroid implant vs intravitreal ranibizumab for the treatment of macular edema: a meta-analysis of randomized controlled trials [PDF]
Drug Design, Development and Therapy, 2019 Qingquan Wei,1,2,* Rui Chen,1,2,* Qiyang Lou,1,2 Jing Yu1,2 1Department of Ophthalmology, Ninghai First Hospital, Zhejiang 315600, People’s Republic of China; 2Department of Ophthalmology, Shanghai Tenth People’s Hospital Affiliated with ...
Wei Q, Chen R, Lou Q, Yu J
doaj +2 more sources
Intravitreal injections of corticosteroid and the risk of central serous chorioretinopathy. [PDF]
PLoS ONECentral serous chorioretinopathy (CSC) is strongly associated with systemic corticosteroid use, but the risk following intravitreal steroid injections remains unclear, with limited evidence from isolated case reports. This study evaluated the association
Jae Ryong Song, Se Joon Woo
doaj +3 more sources
Paraneoplastic vitelliform retinopathy successfully treated with intravitreal dexamethasone implants [PDF]
American Journal of Ophthalmology Case ReportsPurpose: To report a rare case of paraneoplastic vitelliform retinopathy, characterized by detachments of the retinal pigment epithelium and neurosensory retina manifesting as vitelliform lesions, successfully managed with a sustained-release ...
Mariel S. Natividade +5 more
doaj +2 more sources
Early Switch to Dexamethasone Intravitreal Implant in Patients with Diabetic Macular Edema Poorly Responding to Anti-VEGF Therapy: A Narrative Review [PDF]
Ophthalmology and TherapyDiabetic macular edema (DME) is a potential complication of diabetic retinopathy (DR) and a leading cause of DR-related impairment of central vision. The pathogenesis of DME is complex and multifactorial.
Riccardo Sacconi +8 more
doaj +2 more sources
Fluocinolone acetonide implant in diabetic macular edema: sustained benefits and effects of following prior therapy [PDF]
International Journal of Retina and VitreousPurpose To (1) evaluate long-term real-world anatomical and functional outcomes after implantation of a sustained-release fluocinolone acetonide (FAc) implant in eyes with diabetic macular edema (DME) and (2) to assess the influence of prior anti ...
Philipp Necpal +3 more
doaj +2 more sources
Elevated Intraocular Pressure After Intravitreal Steroid Injection in Diabetic Macular Edema: Monitoring and Management [PDF]
Ophthalmology and Therapy, 2016 INTRODUCTION: With the increasing use of intravitreal administration of corticosteroids in macular edema, steroid-induced intraocular pressure (IOP) rise is becoming an emergent issue.
Ingeborg Stalmans +2 more
exaly +2 more sources
Intravitreal Corticosteroid Implantation in Diabetic Macular Edema: Updated European Consensus Guidance on Monitoring and Managing Intraocular Pressure [PDF]
Ophthalmology and Therapy, 2022 Keith Barton +2 more
exaly +2 more sources